Brinker Capital Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-997
Closed -$99K 902
2019
Q3
$99K Sell
997
-337
-25% -$32K ﹤0.01% 370
2019
Q2
$123K Sell
1,334
-79
-6% -$7.5K ﹤0.01% 455
2019
Q1
$133K Sell
1,413
-13,400
-90% -$1.17M ﹤0.01% 374
2018
Q4
$949K Sell
14,813
-14,504
-49% -$1.07M 0.03% 232
2018
Q3
$2.62M Buy
29,317
+28,839
+6,033% +$2.55M 0.08% 157
2018
Q2
$38K Hold
478
﹤0.01% 390
2018
Q1
$43K Sell
478
-63
-12% -$6.05K ﹤0.01% 365
2017
Q4
$56K Sell
541
-127
-19% -$14.3K ﹤0.01% 347
2017
Q3
$97K Buy
668
+119
+22% +$16.2K ﹤0.01% 309
2017
Q2
$71K Buy
549
+8
+1% +$980 ﹤0.01% 314
2017
Q1
$67K Hold
541
﹤0.01% 300
2016
Q4
$63K Buy
541
+468
+641% +$52.1K ﹤0.01% 296
2016
Q3
$8K Buy
+73
New +$7.9K ﹤0.01% 387
2016
Q1
Sell
-13
Closed -$2K 786
2015
Q4
$2K Buy
13
+5
+63% +$578 ﹤0.01% 479
2015
Q3
$1K Buy
+8
New +$993 ﹤0.01% 448
2015
Q2
Sell
-168
Closed -$19K 462
2015
Q1
$19K Buy
+168
New +$20.1K ﹤0.01% 346
2014
Q1
Sell
-6,664
Closed -$563K 435
2013
Q4
$563K Sell
6,664
-238
-3% -$18.8K 0.02% 204
2013
Q3
$532K Sell
6,902
-52
-0.7% -$3.64K 0.02% 199
2013
Q2
$407K Buy
+6,954
New +$418K 0.02% 207

Other funds holding CELG

Brinker Capital Investments's CELG Position: Q4 2019 in Review

Brinker Capital Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 997 shares — an estimated $99K sold.

Brinker Capital Investments first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $2.62M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Brinker Capital Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Brinker Capital Investments sold 997 Celgene Corp shares in Q4 2019, an estimated $99K.
  • Brinker Capital Investments first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Brinker Capital Investments's Celgene Corp position peaked at $2.62M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brinker Capital Investments's 13F filing for Q4 2019, filed 6 Feb 2020.